Affiliation:
1. the Fifth Medical Center of PLA General Hospital
2. Capital Medical University
3. Peking University 302 Clinical Medical School
4. Medical Supplies Center of PLA General Hospital
Abstract
Abstract
Cytosolic DNA activates the STING (stimulator of interferon genes) signaling pathway to trigger interferon and inflammatory responses that protect against microbial infections and cancer. However, Aicardi–Goutières syndrome (AGS) persistently activates the STING signaling pathway, which can lead to severe autoimmune diseases. We demonstrate herein that Licochalcone B (LicoB), the main component of traditional licorice, is an inhibitor of the STING signaling pathway. We observed that LicoB inhibited the activation of the STING signaling pathway in macrophages. Mechanically, LicoB affected the STING-TBK1-IRF3 signal axis and inhibited the activation of the STING downstream signaling pathway. Furthermore, LicoB inhibited the increase in type I interferon levels in mice induced by the STING agonist CMA. LicoB significantly reduced systemic inflammation in Trex1−/− mice. Our results show that LicoB, a STING signaling pathway inhibitor, is a promising candidate for the treatment of diseases related to STING signaling pathway activation.
Publisher
Research Square Platform LLC
Reference40 articles.
1. Nucleic acid recognition by the innate immune system;Barbalat R;Annu Rev Immunol,2011
2. Wu J, Sun L, Chen X, Du F, Shi H, Chen C, Chen ZJ. (2013) Cyclic GMP-AMP is an endogenous second messenger in innate immune signaling by cytosolic DNA, Science (New York, NY). 339, 826 – 30.
3. DNA sensing by the cGAS-STING pathway in health and disease;Motwani M;Nat Rev Genet,2019
4. Structures and Mechanisms in the cGAS-STING Innate Immunity Pathway;Zhang X;Immunity,2020
5. The Cytosolic DNA-Sensing cGAS-STING Pathway in Cancer;Kwon J;Cancer Discov,2020